Redefining Dual Antiplatelet Strategies After Acute Coronary Syndrome: Insights from Recent RCTs. [PDF]
He M +6 more
europepmc +1 more source
Indobufen <i>versus</i> aspirin in dual antiplatelet therapy: a retrospective study of effects on serum uric acid levels and gout attacks in patients post-coronary stenting. [PDF]
Jiang S +7 more
europepmc +1 more source
Epidemiology, Pathophysiology, and Medical Management of Intracranial Atherosclerotic Disease. [PDF]
Itabashi R.
europepmc +1 more source
Clopidogrel-induced drug-induced hypersensitivity syndrome following percutaneous coronary intervention: a case report of therapeutic dilemma and management strategy. [PDF]
Wang S, Zhou J, Sun Y.
europepmc +1 more source
Effect of insulin resistance on ticagrelor-versus clopidogrel-based dual antiplatelet therapy for secondary prevention of stroke in carriers of <i>CYP2C19</i> loss-of-function mutations. [PDF]
Zhao J +11 more
europepmc +1 more source
Comparison of clinical efficacy and bleeding risk between ticagrelor and clopidogrel in elderly patients after percutaneous coronary intervention: A retrospective study. [PDF]
Luo J, Liang G, Chen A.
europepmc +1 more source
Optimal Antithrombotic Regimens Across Atherosclerotic Vascular Beds: Toward Mechanism and Risk-Oriented Strategies. [PDF]
Sabouret P +13 more
europepmc +1 more source
High on-clopidogrel platelet reactivity among diabetic female patients with acute ischaemic stroke. [PDF]
Bustami M +15 more
europepmc +1 more source
Impact of Area-Level Socioeconomic Deprivation on Post-PCI Outcomes Stratified by P2Y<sub>12</sub> Inhibitor Therapy. [PDF]
Malavé JG +12 more
europepmc +1 more source
Efficacy of dual therapy with rivaroxaban and clopidogrel in canine aortic thrombosis resistant to clopidogrel monotherapy: two case reports. [PDF]
Niijima R, Ishino H.
europepmc +1 more source

